Acne Vulgaris
Conditions
Brief summary
To see if teledermatology can be used to reduce antibiotic burden in patients on doxycycline or minocycline for acne vulgaris
Detailed description
The investigators are going to ascertain if antibiotic burden can be reduced with tele dermatology use. There are two arms of the study: 1. Feedback group 2. Non feedback group All subjects will be randomised to either group, all subjects will take photos of their face and answer questions at baseline, visit 2 (1 month), visit 3 (2 months), visit 4 (3 months). The investigators will then use measurements of acne grading (patient grading, investigator global assessment, lesion counting, global acne grading) to reduce/taper antibiotics in the feedback group.
Interventions
OTHERFeedback group
Monitoring ability to use teledermatology to modify antibiotic burden
OTHERNon Feedback group
To use as control to see if antibiotic burden has been reduced in the active feedback group
Sponsors
University of California, Davis
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Subjects aged 15 years and older * Subjects who have been prescribed doxycycline or minocycline by their physician for acne vulgaris but have not initiated treatment yet.
Exclusion criteria
* Subjects who have used isotretinoin in the last 6 weeks * Those who have used oral antibiotics within the last 4 weeks * Those who have been initiated or changed brand of oral contraceptive pill within the last one month. * Those subjects who cannot engage with the teledermatology platform * Prisoners * Adults unable to consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Reduced antibiotic use | Assessed at 4, 8, 12 weeks | The difference in antibiotic exposure in the physician feedback group compared to those not receiving feedback |
Other
| Measure | Time frame | Description |
|---|---|---|
| Change in acne grading (change in patient grading) | Assessed at 4, 8, 12 weeks | Change in Patient Grading |
| Change in acne grading (investigator global assessment) | Assessed at 4, 8, 12 weeks | Change in Investigator Global Assessment |
| Change in acne grading (lesion counting) | Assessed at 4, 8, 12 weeks | Change in Lesion Counting |
| Change in acne grading using the global acne grading | Assessed at 4, 8, 12 weeks | Change in Global Acne Grading |
Countries
United States
Outcome results
None listed